Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 140.40
Bid: 140.10
Ask: 140.40
Change: 2.20 (1.59%)
Spread: 0.30 (0.214%)
Open: 141.50
High: 142.50
Low: 136.80
Prev. Close: 138.20
AML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 2.10 Announcement

21 Dec 2015 14:57

21 December 2015

Amlin plc (the “Company”)

Rule 2.10 Announcement

In accordance with Rule 2.10 of the City Code on Takeovers and Mergers (the “Code”), the Company confirms that, the following number of Shares were transferred from treasury to satisfy the exercise of awards under the Company’s share option schemes.

4,288 ordinary shares at an exercise price of 293.00 pence per share.

867 ordinary shares at an exercise price of 311.00 pence per share.

It had in issue 506,177,051 ordinary shares of 28.125 pence each with ISIN number GB00B2988H17 (“Shares”) in issue as at the date of this announcement.

The total number of Shares attracting voting rights in the Company is 503,352,950.

The above figure may be used by shareholders to determine the percentage of issued share capital they hold in the Company and if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure and Transparency Rules.

Contact:

Mark Stevens

Company Secretary

Amlin plc

020 7746 1000

Disclosure requirements of the Code

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person’s interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person’s interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel’s website at http://www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. If you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure, you should contact the Panel’s Market Surveillance Unit on +44 (0)20 7638 0129.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151221005726/en/

Copyright Business Wire 2015

Date   Source Headline
3rd Aug 20212:35 pmRNSDirector/PDMR Shareholding
29th Jul 202110:00 amRNSTotal Voting Rights
28th Jul 20217:00 amRNSInterim results for the six months to 30 June 2021
26th Jul 20217:00 amRNSHolding(s) in Company
22nd Jul 20217:00 amRNSAdditional Listing
15th Jul 20217:00 amRNSAdditional Listing
8th Jul 20217:00 amRNSDirectorate Change
29th Jun 20212:00 pmRNSDirector/PDMR Shareholding
29th Jun 202110:45 amRNSTotal Voting Rights
22nd Jun 20217:00 amRNSCommencement of legal proceedings
16th Jun 20212:00 pmRNSDirector/PDMR Shareholding
15th Jun 202111:06 amRNSDirector/PDMR Shareholding
28th May 20219:30 amRNSTotal Voting Rights
25th May 20211:00 pmRNSResult of AGM
10th May 202111:00 amRNSDirector/PDMR Shareholding
6th May 20217:00 amRNS1st Quarter Results
29th Apr 20219:30 amRNSTotal Voting Rights
21st Apr 20219:30 amRNSNotice of AGM
19th Apr 20217:15 amRNSDeath of Non-Executive Director
6th Apr 20211:45 pmRNSDirector Declaration - Correction
6th Apr 20211:00 pmRNSDirector Declaration
30th Mar 202110:30 amRNSTotal Voting Rights
11th Mar 202111:34 amRNSAnnual Financial Report
3rd Mar 20212:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20219:30 amRNSDirector/PDMR Shareholding
26th Feb 20219:30 amRNSTotal Voting Rights
25th Feb 20216:04 pmRNSIssue of Debt
25th Feb 202110:30 amRNSIssue of Debt
25th Feb 20217:00 amRNSFinal Results
19th Feb 20211:32 pmRNSDirectorate Change
28th Jan 202112:25 pmRNSTotal Voting Rights
28th Jan 20219:00 amRNSDirectorate Change
30th Dec 202010:00 amRNSTotal Voting Rights
29th Dec 20209:00 amRNSHolding(s) in Company
15th Dec 20209:30 amRNSDirector/PDMR Shareholding
10th Dec 202010:00 amRNSHolding(s) in Company
9th Dec 20204:43 pmRNSDirector/PDMR Shareholding - Replacement
9th Dec 20201:30 pmRNSDirector/PDMR Shareholding
9th Dec 20201:30 pmRNSHolding(s) in Company
9th Dec 20201:30 pmRNSHolding(s) in Company
9th Dec 20209:17 amRNSHolding(s) in Company
7th Dec 20207:00 amRNSAdmission of Placing and Consideration Shares
4th Dec 20209:51 amRNSResult of the General Meeting
30th Nov 202010:00 amRNSTotal Voting Rights
26th Nov 20209:31 amRNSSatisfaction of Antitrust Conditions
18th Nov 20201:40 pmRNSPublication of a Prospectus
13th Nov 20203:25 pmRNSDirectorate Change
5th Nov 20202:00 pmRNSDirector/PDMR Shareholding
30th Oct 20205:25 pmRNSPricing of Senior Secured Notes
30th Oct 20203:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.